Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 44,901 | 56,819 | 65,191 | 60,490 | 71,774 |
| Operating Income | -44,901 | -56,819 | -65,191 | -60,490 | -71,774 |
| Interest Expense | 344 | 268 | 150 | 81 | 100 |
| Other Income | 3,845 | 6,144 | 5,608 | 1,075 | 5,581 |
| Pre-tax Income | -41,400 | -50,943 | -59,733 | -59,496 | -66,293 |
| Net Income Continuous | -41,400 | -50,943 | -59,733 | -59,939 | -66,293 |
| Net Income | $-41,400 | $-50,943 | $-59,733 | $-59,939 | $-66,293 |
| EPS Basic Total Ops | -0.19 | -0.23 | -0.28 | -0.27 | -0.32 |
| EPS Basic Continuous Ops | -0.19 | -0.23 | -0.28 | -0.27 | -0.32 |
| EPS Diluted Total Ops | -0.19 | -0.23 | -0.28 | -0.27 | -0.32 |
| EPS Diluted Continuous Ops | -0.19 | -0.23 | -0.28 | -0.27 | -0.32 |
| EPS Diluted Before Non-Recurring Items | -0.19 | -0.23 | -0.28 | -0.28 | -0.27 |
| EBITDA(a) | $-42,727 | $-54,884 | $-63,398 | $-58,908 | $-70,266 |